Our study discovered that NPC patients with low GNA14 expression had a significant decrease in the proportion of most immune cells, such as B cells, CD4+, and CD8+ T cells, and had lower stromal scores and immunity scores, indicating these patients had higher tumor purity and lower levels of immune infiltration (22). This evidence concerns the gene GNA14 and nasopharyngeal carcinoma.